Market Brief
Montes Claros, Brazil, Sees Increase in Pharma and Biotech Investments, an Industrial Info Market Brief
Pharmaceutical and biotech companies continue to invest in Montes Claros, located north of Mina Gerais, Brazil.
Released Friday, March 29, 2019
Reports related to this article:
Project(s): View 7 related projects in PECWeb
Plant(s): View 3 related plants in PECWeb
Pharmaceutical and biotech companies continue to invest in Montes Claros, located north of Mina Gerais, Brazil. The city has is becoming well known in this segment. As an example, Novo Nordisk is making significant investments in its Montes Claros facilities.
Sanval, a subsidiary of Hipolabo, plans to start operations within two years at its grassroot plant, which represents an investment of more than $18 million.
Click on the image below for a larger view of this graph.
/news/article.jsp
false
Want More IIR News?
Make us a Preferred Source on Google to see more of us when you search.
Add Us On GoogleAsk Us
Have a question for our staff?
Submit a question and one of our experts will be happy to assist you.
Forecasts & Analytical Solutions
Where global project and asset data meets advanced analytics for smarter market sizing and forecasting.
Learn MoreRelated Articles
-
Novo Nordisk Drops $2 Billion Irish ProjectJuly 01, 2024
-
Novo Nordisk Spends $11 Billion to Make More Weight Loss Dru...February 15, 2024
Industrial Project Opportunity Database and Project Leads
Get access to verified capital and maintenance project leads to power your growth.
Learn MoreIndustry Intel
-
From Data to Decisions: How IIR Energy Helps Navigate Market VolatilityOn-Demand Podcast / Nov. 18, 2025
-
Navigating the Hydrogen Horizon: Trends in Blue and Green EnergyOn-Demand Podcast / Nov. 3, 2025
-
ESG Trends & Challenges in Latin AmericaOn-Demand Podcast / Nov. 3, 2025
-
2025 European Transportation & Biofuels Spending OutlookOn-Demand Podcast / Oct. 27, 2025
-
2025 Global Oil & Gas Project Spending OutlookOn-Demand Podcast / Oct. 24, 2025